TNF and psoriasis: Taken together, our data provides evidence that the percentage of CD14+HLA-DR−/low MDSC/ CD14+ cells and TNF-α and FOXP3 mRNA expression levels in PBMCs are potential biomarkers for making a distinction between the psoriasis TCM BS syndrome and BH syndrome.